Skip to main content
. 2019 Nov 27;7(4):198. doi: 10.3390/vaccines7040198

Table 1.

Study groups.

Groups Name Treatment
1 Control Injected with 4T1 cells
2 Vehicle Fed with vehicle daily
Injected with 4T1 cells
3 DC Injected with DC (three times)
Injected with 4T1 cells a week after last DC injection
4 DC + TL Injected with DC + TL (three times)
Injected with 4T1 cells a week after last the DC + TL injection
5 DC + TL + TRF Injected with DC + TL (three times)
Fed with 1 mg TRF daily
Injected with 4T1 cells a week after the last DC + TL injection

DC: dendritic cells; TL: tumor lysate; TRF: tocotrienol-rich fraction; 4T1: murine mammary cancer cells; Vehicle: 50 µL of soy oil.